New ‘Antigens’ in membranous nephropathy

Sanjeev Sethi

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Membranous nephropathy (MN) occurs due to deposition of immune complexes along the subepithelial region of glomerular basement membrane. Two previously identified target antigens for the immune complexes, PLA2R (identified in 2009) and THSD7A (in 2014), account for approximately 60% of all MN, both primary and secondary. In the remaining MN, target antigens were unknown. Use of laser microdissection and mass spectrometry enabled identification of new “antigens.” This approach led to the identification of four novel types of MN: exotosin 1 (EXT1)– and exotosin 2 (EXT2)–associated MN, NELL1-associated MN, Sema3B-associated MN, and PCDH7-associated MN. Each of these represents a distinct disease entity, with different clinical and pathologic findings. In this review, the structure of the proteins and the clinical and pathologic findings of the new types of MN are discussed. The role of mass spectrometry for accurate diagnosis of MN cannot be overemphasized. Finally, any classification of MN should be made on the basis of the antigens that are detected. Further studies are required to understand the pathophysiology, response to treatment, and outcomes of these new MNs.

Original languageEnglish (US)
Pages (from-to)268-278
Number of pages11
JournalJournal of the American Society of Nephrology
Issue number2
StatePublished - Feb 2021

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'New ‘Antigens’ in membranous nephropathy'. Together they form a unique fingerprint.

Cite this